Please join us for a special series of online seminars for people affected by hereditary breast and ovarian cancer.
February 27, 2018
Melinda Telli, MD
What are the newest updates in breast cancer with immunotherapy? Most of the current research is around triple negative breast cancer and individuals who have a BRCA1 or BRCA2 genetic mutation. Join Melinda Telli, MD, Assistant Professor of Medicine (Oncology) Stanford University Medical Center as she discusses these updates.
This webinar has advanced and technical content.